Same Indication

Ipilimumab vs Sildenafil

Ipilimumab vs Sildenafil: Overview

This comparison examines the pharmacological differences between Ipilimumab and Sildenafil.

Mechanism of Action

Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

Sildenafil: Selective PDE5 inhibitor increasing cGMP.

Pharmacokinetics

Half-life: Ipilimumab — 14.7 days; Sildenafil — 4 hours.

Chemical Properties

Molecular Formula: Sildenafil — C22H30N6O4S.

Molecular Weight: Sildenafil — 474.5800 g/mol.

Type: Ipilimumab — Antibody; Sildenafil — Small molecule.